[1]
M. Hilmi Dogu, I. Sari, S. Hacioglu, S. Selcuk, and A. Keskin, “Dramatic Response to Systemic Bevacizumab Therapy in a Patient with Hereditary Hemorrhagic Telangiectasia ”, Ann Med Res , vol. 22, no. 4, pp. 0269–0271, May 2021, Accessed: Aug. 25, 2026. [Online]. Available: http://www.annalsmedres.org/index.php/aomr/article/view/1429